Growth Metrics

Myriad Genetics (MYGN) Long-Term Deferred Tax (2016)

Myriad Genetics has reported Long-Term Deferred Tax over the past 7 years, most recently at $12.7 million for Q2 2016.

  • Quarterly Long-Term Deferred Tax changed N/A to $12.7 million in Q2 2016 from the year-ago period, while the trailing twelve-month figure was $12.7 million through Jun 2016, changed N/A year-over-year, with the annual reading at $12.7 million for FY2016, N/A changed from the prior year.
  • Long-Term Deferred Tax was $12.7 million for Q2 2016 at Myriad Genetics, down from $13.5 million in the prior quarter.
  • Over five years, Long-Term Deferred Tax peaked at $30.6 million in Q2 2012 and troughed at $407000.0 in Q1 2015.
  • The 5-year median for Long-Term Deferred Tax is $27.0 million (2012), against an average of $21.3 million.
  • Year-over-year, Long-Term Deferred Tax increased 21.93% in 2013 and then tumbled 88.82% in 2014.
  • A 5-year view of Long-Term Deferred Tax shows it stood at $24.6 million in 2012, then increased by 21.93% to $30.0 million in 2013, then crashed by 89.33% to $3.2 million in 2014, then skyrocketed by 321.88% to $13.5 million in 2015, then fell by 5.93% to $12.7 million in 2016.
  • Per Business Quant, the three most recent readings for MYGN's Long-Term Deferred Tax are $12.7 million (Q2 2016), $13.5 million (Q4 2015), and $407000.0 (Q1 2015).